Mode
Text Size
Log in / Sign up

IBS-M, IBS-D, and IBS-C patients report higher severity scores and lower quality of lifeIBS Patients with Mixed Stool Patterns Face Higher Symptom Severity

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that IBS-M, IBS-D, and IBS-C patients experience higher symptom severity and lower quality of life than IBS-U.

This cross-sectional post hoc analysis evaluated 483 adult patients newly diagnosed with Irritable Bowel Syndrome (IBS) in a primary care setting. The study assessed clinical and psychosocial characteristics, including Rome IV criteria fulfillment, stool patterns, and severity scores.

Of the patients studied, 70% fulfilled the Rome IV criteria. Stool pattern distribution was 20% IBS-C, 33% IBS-D, 31% IBS-M, and 16% IBS-U. The mean IBS-SSS score was 268 ± 98, with 46% of patients experiencing moderate symptoms and 36% experiencing severe symptoms.

Patients meeting Rome criteria (Rome+) demonstrated significantly higher IBS-SSS scores, lower quality of life, and higher psychosocial comorbidity compared to those who did not. Furthermore, patients with IBS-M, IBS-D, and IBS-C scored significantly higher on both IBS-SSS and IBS-QoL compared to those with IBS-U. Specifically, IBS-M patients showed significantly higher somatic symptom disorder, depression, and anxiety scores compared to IBS-U patients.

Safety and tolerability data were not reported. The study is limited by its design as a post hoc analysis. These findings suggest that specific IBS subtypes, particularly IBS-M, are associated with higher symptom severity and greater psychosocial burden, which may necessitate tailored management approaches.

How this fits prior evidence

How this fits prior evidence: This study addresses a gap in characterizing the clinical and psychosocial profiles of specific IBS subtypes. While previous coverage noted that Mediterranean-based diets may offer superior efficacy over traditional advice for IBS, and that ME/CFS is linked to 7-fold higher odds of IBS, this study provides specific data on the severity and quality of life differences between IBS-M, IBS-D, IBS-C, and IBS-U subtypes.

This observational study looked at 483 adults who were newly diagnosed with Irritable Bowel Syndrome (IBS) by their primary care doctors. The researchers looked at different types of IBS, including those with constipation, diarrhea, mixed symptoms, or unclassified symptoms. They also measured how much these conditions impacted the daily lives and mental health of the patients.

The findings showed that 70% of the patients met the standard criteria for IBS. Patients with mixed, diarrhea, or constipation types reported higher severity scores than those with unclassified symptoms. Specifically, those with the mixed subtype showed significantly higher levels of somatic symptom disorder, depression, and anxiety. These patients also reported a lower quality of life.

Because this was a post hoc analysis of a cross-sectional study, the results show links between certain IBS types and mental health, but they do not prove that one caused the other. The results are specific to this group of newly diagnosed patients. You should talk to your doctor to discuss how these findings relate to your specific diagnosis and symptoms.

What this means for you:
Patients with mixed-type IBS may experience higher symptom severity and more mental health challenges.

Common questions

What are the different types of IBS mentioned?

The study identified four main subtypes: IBS-C (constipation), IBS-D (diarrhea), IBS-M (mixed), and IBS-U (unclassified). Among the 483 patients, 33% had IBS-D, 31% had IBS-M, 20% had IBS-C, and 16% had IBS-U.

How does the mixed type (IBS-M) affect mental health?

Patients with the mixed subtype (IBS-M) showed significantly higher levels of somatic symptom disorder, depression, and anxiety compared to those with the unclassified subtype. These patients also reported a lower quality of life.

How severe were the symptoms for these patients?

The average severity score was 268. Among the patients, 46% experienced moderate symptoms and 36% experienced severe symptoms. Those with mixed, diarrhea, or constipation types scored higher on severity scales than those with unclassified symptoms.

Study Details

Study typeRct
Sample sizen = 483
EvidenceLevel 2
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: The majority of irritable bowel syndrome (IBS) patients are diagnosed and managed in primary care, but this setting is underinvestigated to date. OBJECTIVE: The present study aimed to improve our understanding of IBS in primary care by evaluating the clinical and psychosocial characteristics of affected patients. METHODS: We performed a cross-sectional post hoc analysis of the DOMINO study, which enrolled 483 adult IBS patients newly diagnosed by primary care physicians. We investigated baseline demographics and questionnaires assessing Rome IV criteria and stool pattern subtype, symptom severity (IBS-SSS), quality of life (IBS-QoL), somatic symptom disorder (PHQ-12), depression (PHQ-9) and anxiety (GAD-7). RESULTS: 70% of the primary care diagnosed IBS patients fulfilled the Rome IV criteria (Rome+). The stool pattern subtype distribution according to the Rome IV diagnostic questionnaire was: 20% constipation (IBS-C), 33% diarrhea (IBS-D), 31% mixed (IBS-M) and 16% unclassified (IBS-U). Mean IBS-SSS was 268 ± 98, with 46% and 36% of cases reporting moderate and severe IBS-SSS, respectively. Rome + patients had, compared to Rome-, a significantly higher IBS-SSS, lower quality of life and higher psychosocial comorbidity. IBS-M, IBS-D and IBS-C participants scored significantly higher on IBS-SSS and IBS-QoL than IBS-U. Furthermore, IBS-M had significantly higher somatic symptom disorder and depression and anxiety levels compared with IBS-U. CONCLUSION: The majority of primary care IBS patients fulfilled the Rome IV criteria, were subtyped as IBS-D or IBS-M and were characterised by moderate or severe IBS-SSS. Rome+ and IBS-M participants had higher symptom severity, lower quality of life and higher psychosocial comorbidity. CLINICALTRIALS: gov, Number NCT04270487.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.